GGrantIndex
Sort

172,184 grants matching inflammation

University of Florida Claude D. Pepper Older Americans Independence Center (OAIC)

$1,023,397
Marco Pahor · University Of Florida · P30 · FY2017 · AG

Host Directed Orynotide for MDR Gram Negative Bacterial Infections

$1,023,350
Justin Blaine Schaal · University Of Southern California · R01 · FY2025 · AI

Mitigation of Neurological Damage Following Seizures

$1,023,165
Pamela J Lein · University Of California At Davis · U54 · FY2019 · NS

Studies of Chemokine-Receptor Interactions with Chemokines and alarmins

$1,023,149
Joost J Oppenheim · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves

$1,023,118
Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2023 · HL

NINDS Clinical Proteomics Unit

$1,023,091
Jeffrey Kowalak · National Institute Of Neurological Disorders And Stroke · ZIC · FY2020 · NS

PERSISTENT PAIN: PERIPHERAL AND CNS MECHANISMS

$1,023,082
University Of Utah · P01 · FY2003 · NS

Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion

$1,022,830
Brian Robert Krause · Alphacore Pharma, Llc · R44 · FY2010 · HL

Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis

$1,022,611
Mark W Feinberg · Brigham And Women'S Hospital · U01 · FY2024 · DK

Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis

$1,022,611
Mark W Feinberg · Brigham And Women'S Hospital · U01 · FY2025 · DK

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,022,419
Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,022,419
Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Analysis of Innate Immune Signaling Networks

$1,022,358
Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Preterm Delivery and Maternal Cardiovascular Disease Risk

$1,022,326
Claudia B. Holzman · Michigan State University · R01 · FY2012 · HL

Redox and other mechanistic insights into cancer and cardiovascular diseases

$1,022,146
Paul M Hwang · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

A NOVEL NEUROPROTECTIVE THERAPY FOR ALZHEIMER’S DISEASE

$1,022,134
Menachem Abraham · Klogene Therapeutics, Inc. · R44 · FY2016 · AG

Biomechanics of Leukocytes and Molecular Imaging Agents

$1,022,125
Michael Brandeau Lawrence · University Of Virginia · R01 · FY2009 · EB

Modulation of Human Cells by Virulent Francisella tularensis

$1,021,978
Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Investigation of Sex and Gender Differences in Cardiovascular Risk in Rural Communities

$1,021,923
Amit Jasvant Shah · Emory University · R01 · FY2024 · HL

Cellular Interactions with Thrombospondin

$1,021,874
David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA

Mentoring Translational Researchers in Louisiana

$1,021,844
Augusto C Ochoa · Lsu Health Sciences Center · P30 · FY2017 · GM

General Clinical Research Center

$1,021,752
Richard D Krugman · University Of Colorado Denver · M01 · FY2008 · RR

1/9 Predictors and Mechanisms of Conversion to Psychosis

$1,021,618
Tyrone D Cannon · Yale University · U01 · FY2015 · MH

A Haplotype Map for Multiple Sclerosis

$1,021,472
Stephen L Hauser · University Of California, San Francisco · R01 · FY2014 · NS

Clinical Research on Nonalcoholic Fatty Liver Disease

$1,021,433
Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2011 · DK